NM_023018.5:c.1231C>T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_023018.5(NADK):​c.1231C>T​(p.Arg411Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000311 in 1,609,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

NADK
NM_023018.5 missense

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.96

Publications

4 publications found
Variant links:
Genes affected
NADK (HGNC:29831): (NAD kinase) NADK catalyzes the transfer of a phosphate group from ATP to NAD to generate NADP, which in its reduced form acts as an electron donor for biosynthetic reactions (Lerner et al., 2001 [PubMed 11594753]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26468137).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NADKNM_023018.5 linkc.1231C>T p.Arg411Trp missense_variant Exon 12 of 12 ENST00000341426.9 NP_075394.3 O95544-1A0A024R058

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NADKENST00000341426.9 linkc.1231C>T p.Arg411Trp missense_variant Exon 12 of 12 2 NM_023018.5 ENSP00000341679.5 O95544-1

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152160
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000294
AC:
7
AN:
238496
AF XY:
0.0000387
show subpopulations
Gnomad AFR exome
AF:
0.0000654
Gnomad AMR exome
AF:
0.0000301
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000281
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000261
AC:
38
AN:
1457064
Hom.:
0
Cov.:
56
AF XY:
0.0000248
AC XY:
18
AN XY:
724460
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33450
American (AMR)
AF:
0.0000229
AC:
1
AN:
43724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25966
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39552
South Asian (SAS)
AF:
0.0000585
AC:
5
AN:
85402
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52818
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000252
AC:
28
AN:
1110150
Other (OTH)
AF:
0.0000664
AC:
4
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152278
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41560
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000904
Hom.:
0
Bravo
AF:
0.0000680
ExAC
AF:
0.0000824
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1666C>T (p.R556W) alteration is located in exon 14 (coding exon 13) of the NADK gene. This alteration results from a C to T substitution at nucleotide position 1666, causing the arginine (R) at amino acid position 556 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.045
T
BayesDel_noAF
Benign
-0.30
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;T;.;T
Eigen
Uncertain
0.31
Eigen_PC
Benign
0.22
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Pathogenic
0.98
.;D;D;D
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.26
T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.9
L;L;.;.
PhyloP100
6.0
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-2.8
D;D;D;D
REVEL
Benign
0.21
Sift
Benign
0.18
T;T;D;D
Sift4G
Uncertain
0.022
D;D;D;D
Polyphen
0.98
D;D;.;.
Vest4
0.39
MutPred
0.38
Loss of catalytic residue at R411 (P = 0.053);Loss of catalytic residue at R411 (P = 0.053);.;.;
MVP
0.72
ClinPred
0.55
D
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.32
gMVP
0.74
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751071301; hg19: chr1-1684453; COSMIC: COSV58277866; COSMIC: COSV58277866; API